Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Mark Paul Lappe$1.6B
Market Cap • 18/04/20242017
(há 7 anos)
2020
(4 years ago)
NASDAQ
Listagem
La Jolla
Sede • California141
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
INBXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.